Description
Key Benefits
-
25mg/ml Dual-molecular-weight non-cross-linked HA formulation
-
Medium HA chains (MMW: 1200 – 1500kDA
-
Short HA chains (LMW 200 – 400kDa
-
Contains trehalose in a patented HA–trehalose combination
-
Designed for extended bioregeneration
-
Suitable for face, neck and décolleté
-
Intradermal medium to deep injection
-
Product-specific ex vivo anti-glycation research is available
Clinical Benefits
-
Multi-Weight HA Profile: The combination of low- and medium-molecular-weight HA is intended to provide complementary tissue interactions rather than the volumising behaviour of cross-linked filler gels.
-
Trehalose & Glycation Research: Trehalose is incorporated with HA in the patented formulation. Published human-skin-explant studies have evaluated Resteeme X in models of glycation and reported protective/curative anti-glycation effects under ex vivo conditions.
Product Profile
Resteeme X contains 25 mg/ml non-cross-linked hyaluronic acid, combining MMW HA at 1,200–1,500 kDa with LMW HA at 200–400 kDa, together with trehalose. It is intended for superficial to medium-deep intradermal administration.Procedural technique should follow the approved professional IFU and appropriate practitioner training.







Reviews
There are no reviews yet.